Harrow (HROW) Liabilities and Shareholders Equity (2010 - 2026)

Harrow (HROW) recorded quarterly Liabilities and Shareholders Equity of $419.5 million in Q1 2026, up 5.02% quarter-over-quarter from $399.5 million in Q4 2025, and up 15.21% on a YoY basis from $364.2 million in Q1 2025.

Harrow (HROW) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Harrow's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $419.5 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 15.21% year-over-year to $419.5 million; the TTM figure through Mar 2026 stood at $1.5 billion (up 8.21% YoY), while the FY2025 annual figure was $399.5 million, up 2.7% from the prior year.
  • Liabilities and Shareholders Equity was $419.5 million for Q1 2026 at Harrow, up from $399.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $419.5 million in Q1 2026 to a low of $97.6 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $278.0 million across 5 years, with a median of $306.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity decreased 8.32% in 2022, then soared 188.98% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $157.4 million in 2022, then soared by 98.35% to $312.2 million in 2023, then rose by 24.6% to $389.0 million in 2024, then increased by 2.7% to $399.5 million in 2025, then increased by 5.02% to $419.5 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $419.5 million (Q1 2026), $399.5 million (Q4 2025), and $363.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn 419.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 419.54 Mn
Dec 31, 2025 399.48 Mn
Sep 30, 2025 363.07 Mn
Jun 30, 2025 345.03 Mn
Mar 31, 2025 364.16 Mn
Dec 31, 2024 388.97 Mn
Sep 30, 2024 351.54 Mn
Jun 30, 2024 306.63 Mn
Mar 31, 2024 295.54 Mn
Dec 31, 2023 312.16 Mn
Sep 30, 2023 286.07 Mn
Jun 30, 2023 223.99 Mn
Mar 31, 2023 217.50 Mn
Dec 31, 2022 157.38 Mn
Sep 30, 2022 98.99 Mn
Jun 30, 2022 98.06 Mn
Mar 31, 2022 97.60 Mn
Dec 31, 2021 98.33 Mn
Sep 30, 2021 102.80 Mn
Jun 30, 2021 106.97 Mn